By Najat Kantouar
Deltex Medical said it would propose delisting from London's Alternative Investment Market at its next general meeting.
The medical technology group said Tuesday that it would seek approval for the delisting at its general shareholder meeting on Feb. 12.
The group has so far received letters of intent and irrevocable undertakings in favor of the proposal representing around 53.8% of the company's share capital, it said.
The cancellation is conditional upon the approval of at least 75% of the votes. If the proposal is passed at the general meeting, it will become effective on Feb. 21, Deltex said.
Write to Najat Kantouar at najat.kantouar@wsj.com
(END) Dow Jones Newswires
January 21, 2025 03:22 ET (08:22 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.